Sun Pharma's sales FY 2015-2022

Published by A. Minhas, Oct 23, 2023
During fiscal year 2022, the net sales of the Indian company, Sun Pharmaceutical Industries amounted to around 384 billion Indian rupees, up from about 332 billion rupees in the previous fiscal year.

Sun Pharmaceutical Industries Limited sales value from financial year 2015 to 2022 (in billion Indian rupees)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

June 2023

Region

India

Survey time period

FY 2015 to FY 2022

Supplementary notes

India's financial year starts in April and ends in March. For example, FY 2014 started in April 2013 and ended in March 2014.

One Indian rupee is equal to 0.012 euros and 0.013 U.S. dollars (as of June 2023).

Date of release is the date of access

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Teva "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Teva

Global positioning

5

Key figures

5

Competitors

4

Costs and expenses

3

Regions and segments

3

Further related statistics

14

Further Content: You might find this interesting as well

Statistics

Topics

TevaGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsPfizer
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu